Takeda’s H1 Sales Log Two-Digit Growth Driven by Global Brands, FDA Wraps Up Plant Re-Inspection

Takeda Pharmaceutical said on October 28 that its first-half group revenue rose 12.8% year on year, pushed by double-digit growth of its 14 global brands. For the full year, however, it cut its net profit forecast due to tax handling...read more